{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:37:06Z","timestamp":1783766226384,"version":"3.55.0"},"reference-count":69,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3934\/mbe.2021094","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T05:37:47Z","timestamp":1613972267000},"page":"1813-1832","source":"Crossref","is-referenced-by-count":14,"title":["Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression"],"prefix":"10.3934","volume":"18","author":[{"given":"Marios G.","family":"Krokidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, Greece","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themis P.","family":"Exarchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Vlamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2021094-1","doi-asserted-by":"crossref","unstructured":"C. A. Lane, J. Hardy, J. M Schott, Alzheimer's disease, <i>Eur. J. Neurol.<\/i>, <b>25<\/b> (2017), 59-70.","DOI":"10.1111\/ene.13439"},{"key":"key-10.3934\/mbe.2021094-2","doi-asserted-by":"crossref","unstructured":"H. S. Kwon, S. H. Koh, Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes, <i>Transl. Neurodegener.<\/i>, <b>9<\/b> (2020), 42.","DOI":"10.1186\/s40035-020-00221-2"},{"key":"key-10.3934\/mbe.2021094-3","doi-asserted-by":"crossref","unstructured":"C. Marogianni, M. Sokratous, E. Dardiotis, G. M. Hadjigeorgiou, D. Bogdanos, G. Xiromerisiou, Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson's disease, <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b> (2020), 8421.","DOI":"10.3390\/ijms21228421"},{"key":"key-10.3934\/mbe.2021094-4","doi-asserted-by":"crossref","unstructured":"S. H. Kim, M. Y. Noh, H. J. Kim, K. W. Oh, J. Park, S. Lee, et al., A therapeutic strategy for Alzheimer's disease focused on immune-inflammatory modulation, <i>Dement Neurocogn. Disord.<\/i>, <b>18<\/b> (2019), 33-46.","DOI":"10.12779\/dnd.2019.18.2.33"},{"key":"key-10.3934\/mbe.2021094-5","doi-asserted-by":"crossref","unstructured":"Z. Han, R. Tian, P. Ren, W. Zhou, P. Wang, M. Luo, et al., Parkinson's disease and Alzheimer's disease: a Mendelian randomization study, <i>BMC Med. Genet.<\/i>, <b>19<\/b> (2018), 215.","DOI":"10.1186\/s12881-018-0721-7"},{"key":"key-10.3934\/mbe.2021094-6","doi-asserted-by":"crossref","unstructured":"A. Xie, J. Gao, L. Xu, D. Meng, Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease, <i>Biomed. Res. Int.<\/i>, <b>2014<\/b> (2014), 648740.","DOI":"10.1155\/2014\/648740"},{"key":"key-10.3934\/mbe.2021094-7","doi-asserted-by":"crossref","unstructured":"J. Montaner, L. Ramiro, A. Simats, S. Tiedt, K. Makris, G. C. Jickling, et al., Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke, <i>Nat. Rev. Neurol.<\/i>, <b>16<\/b> (2020), 247-264.","DOI":"10.1038\/s41582-020-0350-6"},{"key":"key-10.3934\/mbe.2021094-8","doi-asserted-by":"crossref","unstructured":"W. J. Lukiw, A. Vergallo, S. Lista, H. Hampel, Y. Zhao, Biomarkers for Alzheimer's disease (AD) and the application of precision medicine, <i>J. Pers. Med.<\/i>, <b>10<\/b> (2020), 138.","DOI":"10.3390\/jpm10030138"},{"key":"key-10.3934\/mbe.2021094-9","doi-asserted-by":"crossref","unstructured":"E. M. Cilento, L. Jin, T. Stewart, M. Shi, L. Sheng, J. Zhang, Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases, <i>J. Neurochem.<\/i>, <b>151<\/b> (2019), 397-416.","DOI":"10.1111\/jnc.14635"},{"key":"key-10.3934\/mbe.2021094-10","doi-asserted-by":"crossref","unstructured":"J. Verheijen, K. Sleegers, Understanding Alzheimer disease at the interface between genetics and transcriptomics, <i>Trends Genet.<\/i>, <b>34<\/b> (2018), 434-447.","DOI":"10.1016\/j.tig.2018.02.007"},{"key":"key-10.3934\/mbe.2021094-11","doi-asserted-by":"crossref","unstructured":"E. Cuyvers, K. Sleegers, Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond, <i>Lancet Neurol.<\/i>, <b>15<\/b> (2016), 857-868.","DOI":"10.1016\/S1474-4422(16)00127-7"},{"key":"key-10.3934\/mbe.2021094-12","doi-asserted-by":"crossref","unstructured":"F. L. Heppner, R. M. Ransohoff, B. Becher, Immune attack: The role of inflammation in Alzheimer disease, <i>Nature<\/i>, <b>16<\/b> (2015), 358-372.","DOI":"10.1038\/nrn3880"},{"key":"key-10.3934\/mbe.2021094-13","doi-asserted-by":"crossref","unstructured":"Y. Yan, A. Zhao, Y. Qui, Y. Li, R. Yan, Y. Wang, et al., Genetic association of FERMT2, HLA-DRB1, CD2AP, and PTK2B polymorphisms with Alzheimer's disease risk in the southern Chinese population, <i>Front. Aging Neurosci.<\/i>, <b>12<\/b> (2020), 16.","DOI":"10.3389\/fnagi.2020.00016"},{"key":"key-10.3934\/mbe.2021094-14","unstructured":"V. Escott-Price, C. Bellenguez, L. S. Wang, S. H. Choi, D. Harold, L. Jones, et al., Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. <i>PLoS One<\/i>, <b>9<\/b> (2014), e94661."},{"key":"key-10.3934\/mbe.2021094-15","doi-asserted-by":"crossref","unstructured":"I. L\u00f3pez Gonz\u00e1lez, P. Garcia-Esparcia, F. Llorens, I. Ferrer, Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies, <i>Int. J. Mol. Sci.<\/i>, <b>17<\/b> (2016), 206.","DOI":"10.3390\/ijms17020206"},{"key":"key-10.3934\/mbe.2021094-16","doi-asserted-by":"crossref","unstructured":"Z. P. Van Acker, M. Bretou, Wim Annaert, Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors, <i>Mol. Neurodegener.<\/i>, <b>14<\/b> (2019), 20.","DOI":"10.1186\/s13024-019-0323-7"},{"key":"key-10.3934\/mbe.2021094-17","doi-asserted-by":"crossref","unstructured":"A. De Roeck, C. Van Broeckhoven, K. Sleegers, The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics, <i>Acta Neuropathol.<\/i>, <b>138<\/b> (2019), 201-220.","DOI":"10.1007\/s00401-019-01994-1"},{"key":"key-10.3934\/mbe.2021094-18","doi-asserted-by":"crossref","unstructured":"C. Reitz, Novel susceptibility loci for Alzheimer's disease, <i>Future Neurol.<\/i>, <b>10<\/b> (2015), 547-558.","DOI":"10.2217\/fnl.15.42"},{"key":"key-10.3934\/mbe.2021094-19","doi-asserted-by":"crossref","unstructured":"C. Bellenguez, C. Charbonnier, B. Grenier-Boley, O. Quenez, K. Le Guennec, G. Nicolas, et al., Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls, <i>Neurobiol. Aging<\/i>, <b>59<\/b> (2017), 220.e1-220.e9.","DOI":"10.1016\/j.neurobiolaging.2017.07.001"},{"key":"key-10.3934\/mbe.2021094-20","doi-asserted-by":"crossref","unstructured":"P. Ciryam, R. Kundra, R. Freer, R. I. Morimoto, C. M. Dobson, M. Vendruscolo, A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation, <i>Proc. Natl. Acad. Sci. USA<\/i>, <b>113<\/b> (2016), 4753-4758.","DOI":"10.1073\/pnas.1516604113"},{"key":"key-10.3934\/mbe.2021094-21","doi-asserted-by":"crossref","unstructured":"L. V. Kalia, A. E. Lang, Parkinson's disease, <i>Lancet<\/i>, <b>386<\/b> (2015), 896-912.","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"key-10.3934\/mbe.2021094-22","doi-asserted-by":"crossref","unstructured":"A. Masato, N. Plotegher, D. Boassa, L. Bubacco, Impaired dopamine metabolism in Parkinson's disease pathogenesis, <i>Mol. Neurodegener.<\/i>, <b>14<\/b> (2019), 35.","DOI":"10.1186\/s13024-019-0332-6"},{"key":"key-10.3934\/mbe.2021094-23","doi-asserted-by":"crossref","unstructured":"M. G. Krokidis, Identification of biomarkers associated with Parkinson's disease by gene expression profiling studies and bioinformatics analysis, <i>AIMS Neurosci.<\/i>, <b>6<\/b> (2019), 333-345.","DOI":"10.3934\/Neuroscience.2019.4.333"},{"key":"key-10.3934\/mbe.2021094-24","doi-asserted-by":"crossref","unstructured":"A. Gr\u00fcnewald, K. R. Kumar, C. M. Sue, New insights into the complex role of mitochondria in Parkinson's disease, <i>Prog. Neurobiol.<\/i>, <b>177<\/b> (2019), 79-93.","DOI":"10.1016\/j.pneurobio.2018.09.003"},{"key":"key-10.3934\/mbe.2021094-25","doi-asserted-by":"crossref","unstructured":"C. A. D. Costa, W. E. Manaa, E. Duplan, F. Checler, The endoplasmic reticulum stress\/unfolded protein response and their contributions to Parkinson's disease physiopathology, <i>Cells<\/i>, <b>9<\/b> (2020), 2495.","DOI":"10.3390\/cells9112495"},{"key":"key-10.3934\/mbe.2021094-26","doi-asserted-by":"crossref","unstructured":"M. Deffains, M. H. Canron, M. Teil, Q. Li, B. Dehay, E. Bezard, et al., L-DOPA regulates \u03b1-synuclein accumulation in experimental parkinsonism, <i>Neuropathol. Appl. Neurobiol.<\/i>, 2020.","DOI":"10.1111\/nan.12678"},{"key":"key-10.3934\/mbe.2021094-27","doi-asserted-by":"crossref","unstructured":"L. P. Dolgacheva, A. V. Berezhnov, E. I. Fedotova, V. P. Zinchenko, A. Y. Abramov, Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease, <i>J. Bioenerg. Biomembr.<\/i>,  <b>51<\/b> (2019), 175-188.","DOI":"10.1007\/s10863-019-09798-4"},{"key":"key-10.3934\/mbe.2021094-28","doi-asserted-by":"crossref","unstructured":"A. Urbizu, K. Beyer, Epigenetics in Lewy body diseases: Impact on gene expression, utility as a biomarker, and possibilities for therapy, <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b> (2020), 4718.","DOI":"10.3390\/ijms21134718"},{"key":"key-10.3934\/mbe.2021094-29","doi-asserted-by":"crossref","unstructured":"D. M. O'Hara, G. Pawar, S. K. Kalia, L. V. Kalia, LRRK2 and \u03b1-Synuclein: Distinct or synergistic players in Parkinson's disease?, <i>Front. Neurosci.<\/i>, <b>14<\/b> (2020), 577.","DOI":"10.3389\/fnins.2020.00577"},{"key":"key-10.3934\/mbe.2021094-30","doi-asserted-by":"crossref","unstructured":"T. K. Lin, K. J. Lin, K. L. Lin, C. W. Liou, S. D. Chen, Y. C. Chuang, et al., When friendship turns sour: effective communication between mitochondria and intracellular organelles in Parkinson's disease, <i>Front. Cell. Dev. Biol.<\/i>, <b>8<\/b> (2020), 607392.","DOI":"10.3389\/fcell.2020.607392"},{"key":"key-10.3934\/mbe.2021094-31","doi-asserted-by":"crossref","unstructured":"B. Wang, K. R. Stanford, M. Kundu, ER-to-Golgi trafficking and its implication in neurological diseases, <i>Cells<\/i>, <b>9<\/b> (2020), 408.","DOI":"10.3390\/cells9020408"},{"key":"key-10.3934\/mbe.2021094-32","doi-asserted-by":"crossref","unstructured":"T. M. Axelsen, D. P. D. Woldbye, Gene therapy for Parkinson's disease, an update, <i>J. Parkinsons Dis.<\/i>, <b>8<\/b> (2018), 195-215.","DOI":"10.3233\/JPD-181331"},{"key":"key-10.3934\/mbe.2021094-33","doi-asserted-by":"crossref","unstructured":"T. J. Collier, D. E. Jr. Redmond, K. Steece-Collier, J. W. Lipton, F. P. Manfredsson, Is a-synuclein loss-of-function a contributor to parkinsonian pathology? Evidence from non-human primates, <i>Front. Neurosci.<\/i>, <b>10<\/b> (2016), 12.","DOI":"10.3389\/fnins.2016.00012"},{"key":"key-10.3934\/mbe.2021094-34","doi-asserted-by":"crossref","unstructured":"C. Klein, N. Hattori, C. Marras, MDSGene: Closing data gaps in genotype-phenotype correlations of monogenic Parkinson's disease, <i>J. Parkinsons Dis.<\/i>, <b>8<\/b> (2018), S25-S30.","DOI":"10.3233\/JPD-181505"},{"key":"key-10.3934\/mbe.2021094-35","doi-asserted-by":"crossref","unstructured":"J. Chi, Q. Xie, J. Jia, X. Liu, J. Sun, Y. Deng, L. Yi, Integrated analysis and identification of novel biomarkers in Parkinson's disease, <i>Front. Aging Neurosci.<\/i>, <b>10<\/b> (2018), 178.","DOI":"10.3389\/fnagi.2018.00178"},{"key":"key-10.3934\/mbe.2021094-36","doi-asserted-by":"crossref","unstructured":"Y. I. Li, G. Wong, J. Humphrey, T. Raj, Prioritizing Parkinson's disease genes using population-scale transcriptomic data, <i>Nat. Commun.<\/i>, <b>10<\/b> (2019), 994.","DOI":"10.1038\/s41467-019-08912-9"},{"key":"key-10.3934\/mbe.2021094-37","doi-asserted-by":"crossref","unstructured":"K. J. Karczewski, M. P. Snyder, Integrative omics for health and disease, <i>Nat. Rev. Genet.<\/i>, <b>19<\/b> (2018), 299-310.","DOI":"10.1038\/nrg.2018.4"},{"key":"key-10.3934\/mbe.2021094-38","doi-asserted-by":"crossref","unstructured":"B. Wang, V. Kumar, A. Olson, D. Ware, Reviving the transcriptome studies: an insight into the emergence of single-molecule transcriptome sequencing, <i>Front. Genet.<\/i>, <b>10<\/b> (2019), 384.","DOI":"10.3389\/fgene.2019.00384"},{"key":"key-10.3934\/mbe.2021094-39","doi-asserted-by":"crossref","unstructured":"F. R. Pinu, S. A. Goldansaz, J. Jaine, Translational metabolomics: current challenges and future opportunities, <i>Metabolites<\/i>, <b>9<\/b> (2019), 108.","DOI":"10.3390\/metabo9060108"},{"key":"key-10.3934\/mbe.2021094-40","doi-asserted-by":"crossref","unstructured":"J. L. Ren, A. H. Zhang, L. Kong, X. J. Wang, Advances in mass spectrometry-based metabolomics for investigation of metabolites, <i>RSC Adv.<\/i>, <b>8<\/b> (2018), 22335.","DOI":"10.1039\/C8RA01574K"},{"key":"key-10.3934\/mbe.2021094-41","doi-asserted-by":"crossref","unstructured":"J. M. Wilkins, E. Trushina, Application of metabolomics in Alzheimer's disease, <i>Front. Neurol.<\/i>, <b>8<\/b> (2018), 719.","DOI":"10.3389\/fneur.2017.00719"},{"key":"key-10.3934\/mbe.2021094-42","doi-asserted-by":"crossref","unstructured":"E. Trushina, T. Dutta, X. M. Persson, M. M. Mielke, R. C. Petersen, Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics, <i>PLoS One<\/i>, <b>8<\/b> (2013), e63644.","DOI":"10.1371\/journal.pone.0063644"},{"key":"key-10.3934\/mbe.2021094-43","doi-asserted-by":"crossref","unstructured":"G. Paglia, M. Stocchero, S. Cacciatore, S. Lai, P. Angel, M. T. Alam, et al., Unbiased metabolomic investigation of Alzheimer's disease brain points to dysregulation of mitochondrial aspartate metabolism, <i>J. Proteome Res.<\/i>, <b>15<\/b> (2016), 608-618.","DOI":"10.1021\/acs.jproteome.5b01020"},{"key":"key-10.3934\/mbe.2021094-44","doi-asserted-by":"crossref","unstructured":"S. G. Snowden, A. A. Ebshiana, A. Hye, Y. An, O. Pletnikova, R. O'Brien, et al., Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study, <i>PLoS Med.<\/i>, <b>14<\/b> (2017), e1002266.","DOI":"10.1371\/journal.pmed.1002266"},{"key":"key-10.3934\/mbe.2021094-45","doi-asserted-by":"crossref","unstructured":"S. P. Guiraud, I. Montoliu, L. Da Silva, L. Dayon, A. N. Galindo, J. Corthesy, et al., High-throughput and simultaneous quantitative analysis of homo-cysteine-methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC-MS\/MS, <i>Anal. Bioanal. Chem.<\/i>, <b>409<\/b> (2017), 295-305.","DOI":"10.1007\/s00216-016-0003-1"},{"key":"key-10.3934\/mbe.2021094-46","doi-asserted-by":"crossref","unstructured":"J. B. Toledo, M. Arnold, G. Kastenmuller, R. Chang, R. A. Baillie, X. Han, et al., Metabolic network failures in Alzheimer's disease-a biochemical road map, <i>Alzheimers Dement.<\/i>, <b>13<\/b> (2017), 965-84.","DOI":"10.1016\/j.jalz.2017.01.020"},{"key":"key-10.3934\/mbe.2021094-47","doi-asserted-by":"crossref","unstructured":"S. F. Graham, O. P. Chevallier, C. T. Elliott, C. Holscher, J. Johnston, B. McGuinness, et al., Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and l-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease, <i>PLoS One<\/i>, <b>10<\/b> (2015), e0119452.","DOI":"10.1371\/journal.pone.0119452"},{"key":"key-10.3934\/mbe.2021094-48","doi-asserted-by":"crossref","unstructured":"M. Mapstone, F. Lin, M. A. Nalls, A. K. Cheema, A. B. Singleton, M. S. Fiandaca, et al., What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease, <i>Neurobiol. Aging<\/i>, <b>51<\/b> (2017), 148-55.","DOI":"10.1016\/j.neurobiolaging.2016.11.007"},{"key":"key-10.3934\/mbe.2021094-49","doi-asserted-by":"crossref","unstructured":"M. Benson, Clinical implications of omics and systems medicine: focus on predictive and individualized treatment, <i>J. Intern. Med.<\/i>, <b>279<\/b> (2016), 229-240.","DOI":"10.1111\/joim.12412"},{"key":"key-10.3934\/mbe.2021094-50","doi-asserted-by":"crossref","unstructured":"C. Evans, J. Hardin, D. M. Stoebel, Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions, <i>Brief Bioinform.<\/i>, <b>19<\/b> (2018), 776-792.","DOI":"10.1093\/bib\/bbx008"},{"key":"key-10.3934\/mbe.2021094-51","doi-asserted-by":"crossref","unstructured":"F. Maleki, K. Ovens, D. J. Hogan, A. J. Kusalik, Gene set analysis: challenges, opportunities, and future research, <i>Front. Genet.<\/i>, <b>11<\/b> (2020), 654.","DOI":"10.3389\/fgene.2020.00654"},{"key":"key-10.3934\/mbe.2021094-52","doi-asserted-by":"crossref","unstructured":"I. Ihnatova, V. Popovici, E. Budinska, A critical comparison of topology-based pathway analysis methods, <i>PLoS One<\/i>, <b>13<\/b> (2018), e0191154.","DOI":"10.1371\/journal.pone.0191154"},{"key":"key-10.3934\/mbe.2021094-53","unstructured":"N. Xie, L. Zhang, W. Gao, C. Huang, P. E. Huber, X. Zhou, et al., Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways, <i>Signal. Transduct. Target. Ther.<\/i>, <b>5<\/b> (2020), 227."},{"key":"key-10.3934\/mbe.2021094-54","doi-asserted-by":"crossref","unstructured":"Q. Yang, S. Wang, E. Dai, S. Zhou, D. Liu, H. Liu, et al., Pathway enrichment analysis approach based on topological structure and updated annotation of pathway, <i>Brief Bioinform.<\/i>, <b>20<\/b> (2019), 168-177.","DOI":"10.1093\/bib\/bbx091"},{"key":"key-10.3934\/mbe.2021094-55","doi-asserted-by":"crossref","unstructured":"P. Kong, P. Lei, S. Zhang, D. Li, J. Zhao, B. Zhang, Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease, <i>Neurosci. Lett.<\/i>, <b>662<\/b> (2018), 51-58.","DOI":"10.1016\/j.neulet.2017.09.051"},{"key":"key-10.3934\/mbe.2021094-56","doi-asserted-by":"crossref","unstructured":"M. G. Krokidis, P. Vlamos, Transcriptomics in amyotrophic lateral sclerosis, <i>Front. Biosci. (Elite Ed)<\/i>, <b>10<\/b> (2018), 103-121.","DOI":"10.2741\/e811"},{"key":"key-10.3934\/mbe.2021094-57","doi-asserted-by":"crossref","unstructured":"L. Bravo-Merodio, L. A. Williams, G. V. Gkoutos, A. Acharjee, Omics biomarker identification pipeline for translational medicine. <i>J. Transl. Med.<\/i>, <b>17<\/b> (2019), 155.","DOI":"10.1186\/s12967-019-1912-5"},{"key":"key-10.3934\/mbe.2021094-58","doi-asserted-by":"crossref","unstructured":"M. A. Myszczynska, P. N. Ojamies, A. M. B. Lacoste, D. Neil, A. Saffari, R. Mead, et al., Applications of machine learning to diagnosis and treatment of neurodegenerative diseases, <i>Nat. Rev. Neurol.<\/i>, <b>16<\/b> (2020), 440-456.","DOI":"10.1038\/s41582-020-0377-8"},{"key":"key-10.3934\/mbe.2021094-59","doi-asserted-by":"crossref","unstructured":"J. Xin, X. Ren, L. Chen, Y. Wang, Identifying network biomarkers based on protein-protein interactions and expression data, <i>BMC Med. Genomics<\/i>, <b>8<\/b> (2015), S11.","DOI":"10.1186\/1755-8794-8-S2-S11"},{"key":"key-10.3934\/mbe.2021094-60","doi-asserted-by":"crossref","unstructured":"L. Fu, K. Fu, Analysis of Parkinson's disease pathophysiology using an integrated genomics-bioinformatics approach, <i>Pathophysiology<\/i>, <b>22<\/b> (2015), 15-29.","DOI":"10.1016\/j.pathophys.2014.10.002"},{"key":"key-10.3934\/mbe.2021094-61","doi-asserted-by":"crossref","unstructured":"R. Al-Ouran, Y. W. Wan, C. G. Mangleburg, T. V. Lee, K. Allison, J. M. Shulman, et al., A portal to visualize transcriptome profiles in mouse models of neurological disorders, <i>Genes (Basel)<\/i>, <b>10<\/b> (2019), E759.","DOI":"10.3390\/genes10100759"},{"key":"key-10.3934\/mbe.2021094-62","doi-asserted-by":"crossref","unstructured":"J. Kelly, R. Moyeed, C. Carroll, D. Albani, X. Li, Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease, <i>Mol. Brain.<\/i>, <b>12<\/b> (2019), 16.","DOI":"10.1186\/s13041-019-0436-5"},{"key":"key-10.3934\/mbe.2021094-63","doi-asserted-by":"crossref","unstructured":"E. Mariani, F. Frabetti, A. Tarozzi, M. C. Pelleri, F. Pizzetti, R. Casadei, Meta-analysis of Parkinson's disease transcriptome data using TRAM software: whole substantia nigra tissue and single dopamine neuron differential gene expression, <i>PLoS One<\/i>, <b>11<\/b> (2016), e0161567.","DOI":"10.1371\/journal.pone.0161567"},{"key":"key-10.3934\/mbe.2021094-64","doi-asserted-by":"crossref","unstructured":"P. Kong, P. Lei, S. Zhang, D. Li, J. Zhao, B. Zhang, Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease, <i>Neurosci. Lett.<\/i>, <b>662<\/b> (2018), 51-58.","DOI":"10.1016\/j.neulet.2017.09.051"},{"key":"key-10.3934\/mbe.2021094-65","doi-asserted-by":"crossref","unstructured":"E. Glaab, Computational systems biology approaches for Parkinson's disease, <i>Cell Tissue Res.<\/i>, <b>373<\/b> (2018), 91-109.","DOI":"10.1007\/s00441-017-2734-5"},{"key":"key-10.3934\/mbe.2021094-66","doi-asserted-by":"crossref","unstructured":"T. M. Nguyen, A. Shafi, T. Nguyen, S. Draghici, Identifying significantly impacted pathways: a comprehensive review and assessment, <i>Genome Biol.<\/i>, <b>20<\/b> (2019), 203.","DOI":"10.1186\/s13059-019-1790-4"},{"key":"key-10.3934\/mbe.2021094-67","doi-asserted-by":"crossref","unstructured":"J. Ma, A. Shojaie, G. Michailidis, A comparative study of topology-based pathway enrichment analysis methods, <i>BMC Bioinform.<\/i>, <b>20<\/b> (2019), 546.","DOI":"10.1186\/s12859-019-3146-1"},{"key":"key-10.3934\/mbe.2021094-68","doi-asserted-by":"crossref","unstructured":"C. Gao, H. Sun, T. Wang, M. Tang, N. I. Bohnen, M. L. T. M. M\u00fcller, et al., Model-based and model-free machine learning techniques for diagnostic prediction and classification of clinical outcomes in Parkinson's disease, <i>Sci. Rep.<\/i>, <b>8<\/b> (2018), 7129.","DOI":"10.1038\/s41598-018-24783-4"},{"key":"key-10.3934\/mbe.2021094-69","doi-asserted-by":"crossref","unstructured":"Y. Hu, Z. Pan, Y. Hu, L. Zhang, J. Wang, Network and pathway-based analyses of genes associated with Parkinson's disease, <i>Mol. Neurobiol.<\/i>, <b>54<\/b> (2017), 4452-4465.","DOI":"10.1007\/s12035-016-9998-8"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2021094?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T05:41:17Z","timestamp":1613972477000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2021094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2021094","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}